Last Price
3.64
Today's Change
+0.06 (1.67%)
Day's Change
3.52 - 3.71
Trading Volume
1,063,466
Market Cap
436 Million
Shares Outstanding
120 Million
Avg Volume
1,335,987
Avg Price (50 Days)
4.02
Avg Price (200 Days)
6.03
PE Ratio
-1.68
EPS
-2.17
Earnings Announcement
01-Nov-2024
Previous Close
3.58
Open
3.57
Day's Range
3.52 - 3.71
Year Range
3.28 - 9.86
Trading Volume
1,063,466
1 Day Change
1.68%
5 Day Change
3.70%
1 Month Change
-10.12%
3 Month Change
-36.25%
6 Month Change
-36.47%
Ytd Change
-58.45%
1 Year Change
-45.26%
3 Year Change
-76.32%
5 Year Change
-76.32%
10 Year Change
-76.32%
Max Change
-76.32%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.